Last updated on August 2018

A Study to Evaluate the Use of Glucocorticoids in Combination With Tocilizumab in Daily Clinical Practice


Brief description of study

This prospective, multicenter, observational study will evaluate the use of concomitant glucocorticoid therapy in adults with rheumatoid arthritis (RA) being treated with tocilizumab in daily clinical practice. Participants will be observed for up to 52 weeks after starting treatment with tocilizumab. All visits and assessments will be performed as per routine clinical practice, with no study-specific visits or interventions.

Clinical Study Identifier: NCT03291457

Contact Investigators or Research Sites near you

Start Over

Reference Study ID Number: ML39114 ...

Medseen
Houthulst, Belgium
4.94miles
  Connect »

Reference Study ID Number: ML39114 ...

AZ Sint Augustinus Veurne
Veurne, Belgium
8.7miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.